387 related articles for article (PubMed ID: 18499289)
1. Novel prostate brachytherapy technique: improved dosimetric and clinical outcome.
Nobes JP; Khaksar SJ; Hawkins MA; Cunningham MJ; Langley SE; Laing RW
Radiother Oncol; 2008 Jul; 88(1):121-6. PubMed ID: 18499289
[TBL] [Abstract][Full Text] [Related]
2. Is a loose-seed nomogram still valid for prostate brachytherapy in a stranded-seed era?
Kudchadker RJ; Swanson DA; Kuban DA; Lee AK; Bruno TL; Frank SJ
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):623-7. PubMed ID: 18410998
[TBL] [Abstract][Full Text] [Related]
3. The impact of hormone therapy on post-implant dosimetry and outcome following Iodine-125 implant monotherapy for localised prostate cancer.
Ash D; Al-Qaisieh B; Bottomley D; Carey B; Joseph J
Radiother Oncol; 2005 Jun; 75(3):303-6. PubMed ID: 15890423
[TBL] [Abstract][Full Text] [Related]
4. AnchorSeed for the reduction of source movement in prostate brachytherapy with the Mick applicator implant technique.
Badwan HO; Shanahan AE; Adams MA; Shanahan TG; Mueller PW; Markwell SJ; Tarter TH
Brachytherapy; 2010; 9(1):23-6. PubMed ID: 19762286
[TBL] [Abstract][Full Text] [Related]
5. Factors predicting an increased dose to the penile bulb in permanent seed prostate brachytherapy.
Taussky D; Haider M; McLean M; Yeung I; Williams T; Pearson S; Lockwood G; Crook J
Brachytherapy; 2004; 3(3):125-9. PubMed ID: 15533803
[TBL] [Abstract][Full Text] [Related]
6. Improvements in prostate brachytherapy dosimetry due to seed stranding.
Lin K; Lee SP; Cho JS; Reiter RE; DeMarco JJ; Solberg TD
Brachytherapy; 2007; 6(1):44-8. PubMed ID: 17284385
[TBL] [Abstract][Full Text] [Related]
7. Predictive factors for erectile dysfunction in men with prostate cancer after brachytherapy: is dose to the penile bulb important?
Macdonald AG; Keyes M; Kruk A; Duncan G; Moravan V; Morris WJ
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):155-63. PubMed ID: 16111584
[TBL] [Abstract][Full Text] [Related]
8. The radiation doses to erectile tissues defined with magnetic resonance imaging after intensity-modulated radiation therapy or iodine-125 brachytherapy.
Buyyounouski MK; Horwitz EM; Uzzo RG; Price RA; McNeeley SW; Azizi D; Hanlon AL; Milestone BN; Pollack A
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1383-91. PubMed ID: 15275723
[TBL] [Abstract][Full Text] [Related]
9. Loose seeds vs. stranded seeds: a comparison of critical organ dosimetry and acute toxicity in (125)I permanent implant for low-risk prostate cancer.
Saibishkumar EP; Borg J; Yeung I; Cummins-Holder C; Landon A; Crook JM
Brachytherapy; 2008; 7(2):200-5. PubMed ID: 18362087
[TBL] [Abstract][Full Text] [Related]
10. Erectile function durability following permanent prostate brachytherapy.
Taira AV; Merrick GS; Galbreath RW; Butler WM; Wallner KE; Kurko BS; Anderson R; Lief JH
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):639-48. PubMed ID: 19303721
[TBL] [Abstract][Full Text] [Related]
11. Sequential comparison of seed loss and prostate dosimetry of stranded seeds with loose seeds in 125I permanent implant for low-risk prostate cancer.
Saibishkumar EP; Borg J; Yeung I; Cummins-Holder C; Landon A; Crook J
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):61-8. PubMed ID: 18823713
[TBL] [Abstract][Full Text] [Related]
12. 4D Brachytherapy, a novel real-time prostate brachytherapy technique using stranded and loose seeds.
Langley SE; Laing RW
BJU Int; 2012 Feb; 109 Suppl 1():1-6. PubMed ID: 22239223
[TBL] [Abstract][Full Text] [Related]
13. The dosimetry of brachytherapy-induced erectile dysfunction.
Merrick GS; Butler WM
Med Dosim; 2003; 28(4):271-4. PubMed ID: 14684193
[TBL] [Abstract][Full Text] [Related]
14. There is no correlation between erectile dysfunction and dose to penile bulb and neurovascular bundles following real-time low-dose-rate prostate brachytherapy.
Solan AN; Cesaretti JA; Stone NN; Stock RG
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1468-74. PubMed ID: 18922652
[TBL] [Abstract][Full Text] [Related]
15. Rectal morbidity following I-125 prostate brachytherapy in relation to dosimetry.
Ohashi T; Yorozu A; Toya K; Saito S; Momma T; Nagata H; Kosugi M
Jpn J Clin Oncol; 2007 Feb; 37(2):121-6. PubMed ID: 17255159
[TBL] [Abstract][Full Text] [Related]
16. Favorable toxicity and biochemical control using real-time inverse optimization technique for prostate brachytherapy.
Raben A; Rusthoven KE; Sarkar A; Glick A; Benge B; Jacobs D; Raben D
Brachytherapy; 2009; 8(3):297-303. PubMed ID: 19213608
[TBL] [Abstract][Full Text] [Related]
17. The importance of radiation doses to the penile bulb vs. crura in the development of postbrachytherapy erectile dysfunction.
Merrick GS; Butler WM; Wallner KE; Lief JH; Anderson RL; Smeiles BJ; Galbreath RW; Benson ML
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(4):1055-62. PubMed ID: 12419431
[TBL] [Abstract][Full Text] [Related]
18. Variability of prostate brachytherapy pre-implant dosimetry: a multi-institutional analysis.
Merrick GS; Butler WM; Wallner KE; Blasko JC; Michalski J; Aronowitz J; Grimm P; Moran BJ; McLaughlin PW; Usher J; Lief JH; Allen ZA
Brachytherapy; 2005; 4(4):241-51. PubMed ID: 16344253
[TBL] [Abstract][Full Text] [Related]
19. (125)I monotherapy using D90 implant doses of 180 Gy or greater.
Kao J; Stone NN; Lavaf A; Dumane V; Cesaretti JA; Stock RG
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):96-101. PubMed ID: 17980505
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the precision of seeds deposited as loose seeds versus suture embedded seeds: a randomized trial.
Kaplan ID; Meskell PM; Lieberfarb M; Saltzman B; Berg S; Holupka EJ
Brachytherapy; 2004; 3(1):7-9. PubMed ID: 15110307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
